Investigative Ophthalmology & Visual Science Cover Image for Volume 58, Issue 8
June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Long term protection of cone photoreceptors in a mouse model of Leber congenital amaurosis-1 by deletion of S-opsin
Author Affiliations & Notes
  • Nduka Enemchukwu
    Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, United States
  • HUI XU
    Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, United States
    Interdepartmental Program in Neuroscience, University of Utah, Salt Lake City, Utah, United States
  • Mackenzie Parker
    Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, United States
    Rice University, Houston, Texas, United States
  • Lynn Zhu
    Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, United States
    Rice University, Houston, Texas, United States
  • Yingbin Fu
    Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Nduka Enemchukwu, None; HUI XU, None; Mackenzie Parker, None; Lynn Zhu, None; Yingbin Fu, None
  • Footnotes
    Support  Knights Templar Eye Foundation Career-Starter Grant
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4530. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nduka Enemchukwu, HUI XU, Mackenzie Parker, Lynn Zhu, Yingbin Fu; Long term protection of cone photoreceptors in a mouse model of Leber congenital amaurosis-1 by deletion of S-opsin. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4530.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Mutations in GUCY2D, the gene encoding guanylate cyclase 1 (GC1), cause Leber congenital amaurosis-1 (LCA1), the most severe form of early-onset inherited blinding disease. Previous studies have shown that both medium (M)- and short-wavelength (S)-opsins are mislocalized in GC1 knockout Gucy2e-/- mice. In addition, ventral and central cones degenerate more rapidly than dorsal cones in Gucy2e-/- mice. The objectives were to investigate why ventral and central cones degenerate much more rapidly than dorsal cones in this murine LCA1 model.

Methods : We used the Gucy2e-/- mouse model to examine our hypothesis that mouse S-opsin is more likely to cause cone degeneration than mouse M-opsin in LCA1 mouse model. Subcellular localization of mouse M and S opsins was examined by immunohistochemistry. The mRNA and protein levels of cone opsins were analyzed by real-time RT-PCR and western blotting, respectively, at two stages of cone degeneration, 1) 2-week, pre-degeneration, and 2) 5-week, early-stage degeneration. The role of S-opsin in Gucy2e-/- cone degeneration was determined by genetic deletion of S-opsin and assessment of cone survival.

Results : Although both M and S cone opsins mistrafficked, as reported previously, mislocalized M-opsin was degraded whereas mislocalized S-opsin accumulated in Gucy2e-/- cones before the onset of massive ventral/central cone degeneration. Whereas approximately 90% of the cones in the central and ventral regions of Gucy2e–/– retina, respectively, degenerated within ten weeks, deletion of a single allele of S-opsin (Gucy2e–/–Opn1sw+/–) maintained 50% of the cones in the central and ventral regions for at least 10 weeks. By six months, all central and ventral region cones in Gucy2e–/– were degenerated. However, deletion of both alleles of S-opsin (Gucy2e–/–Opn1sw–/–) maintained 100% of the cones in the central and ventral regions for at least nine months. These findings suggest a dose dependent and progressive pathological effect of S-opsin in Gucy2e–/– retinas.

Conclusions : Our results suggest that S-opsin accumulation is responsible for the rapid cone degeneration in the central and ventral retina of Gucy2e–/– mice.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×